Bookedited by Zaheer-Ud-Din Babar.
Contents:
1. Access to high cost medicines: an overview
2. Health technology assessment
3. High-cost medicines in England
4. Managed entry agreements and high cost medicine (European perspective)
5. Setting a public health agenda to support access to high-cost medicines
6. Human rights and intellectural property for universal access to new essential medicines
7. Access to high price medicines in Portugal
8. Improving access to high-cost medicines in low income countries in Africa: creating a functioning pharmaceutical system in Uganda
9. Equitable access to biosimilars: an overview
10. Access to high-cost medicines in Europe
11. Access to high-cost medicines in Australia
12. Access to high-cost medicines in New Zealand
13. Access to high-cost medicines in Wales
Index.